#PublicHealth Archives

Dr. Lai Wei: Interpretation of Key Points from the 2024 Edition of the Chinese Guidelines for the Prevention and Treatment of Metabolic (Non-Alcoholic

By Lisa Cui 2024.10.15

Editor's note: Liver diseases, primarily viral hepatitis, metabolic-associated fatty liver disease (MAFLD), and alcoholic liver disease, affect approximately 400 million people in China. With the increasing pace of life, unhealthy…

Insights from Dr. Khalil Ghanem on the Challenges and Future of Syphilis Diagnosis, Treatment, and Prevention

By Ren Jiamo 2024.10.15

Editor's Note: As the incidence of syphilis continues to rise, clinicians are faced with an increasing number of patients with complex clinical presentations, posing significant challenges in patient management. At…

Dr. Shuihua Lu: Expanding from Tuberculosis-Free Communities to Tuberculosis-Free Cities with the Power of Technology丨15th Tuberculosis Eastern Forum

By Mourabit Halima 2024.10.09

Editor's Note: The convergence of innovation and knowledge flows through Shenzhen, a city in the Greater Bay Area. The "2024 Annual Meeting of the National Clinical Research Center for Infectious…

Hepatology丨Chinese Researchers Confirm that the EAT-Lancet Diet Significantly Reduces the Risk of Metabolic-Associated Fatty Liver Disease

By Mourabit Halima 2024.09.02

Editor's Note With the global rise in obesity, diabetes, and metabolic syndrome, the prevalence of metabolic-associated fatty liver disease (MASLD) is also increasing. Statistics show that MASLD has become one…

New Strategies for Bacterial STI Prevention: The CDC Officially Incorporates Doxy PEP into Guidelines

By Mourabit Halima 2024.09.02

Editor's Note: Recently, the U.S. Centers for Disease Control and Prevention (CDC) released an important clinical guideline offering new guidance on the prevention of bacterial sexually transmitted infections (STIs). The…

Are OTC Eye Drops Safe? CRPA Outbreaks in Multiple U.S. States Trace Back to Artificial Tears

By Mourabit Halima 2024.08.30

Editor's Note: Artificial tears are substitutes that mimic the composition of natural tears, providing lubrication to the eyes and alleviating symptoms of dry eye, such as pain and burning. However,…

Dr. Wenshi Wang’s Team: Three Latest Research Findings on Hepatitis D and Hepatitis E Included in Conference Exchange

By Mourabit Halima 2024.01.22

Hepatitis D (HDV) is a viral hepatitis caused by hepatitis D virus (HDV) infection, often occurring as a co-infection or superinfection with hepatitis B virus (HBV). Approximately 90% of chronic hepatitis B patients who become co-infected with HDV develop chronic hepatitis, increasing the risk of adverse outcomes such as liver failure, cirrhosis, and liver cancer. Due to the historical underestimation of HDV prevalence and disease burden, it has not received the attention it deserves. Hepatitis E virus (HEV) infection is a major cause of acute hepatitis globally, with no specific antiviral drugs available.